免疫功坊股份有限公司 IMMUNWORK
  • ( EN )
    • EN
    • 繁中
    CLOSE
  • About Us
    • Back
    • Overview
    • Founder
    • Executives
    • Board of directors
  • Technologies
    • Back
    • Overview
    • T-ETMPharmaceuticals
    • Multi-arm linkers
    • Packed multi-arm linkers
    • Cytotoxic drug bundles
    • Chelator bundles
    • Fatty acid bundles
    • Antibody drug conjugates
    • Antibody radionuclide conjugates
    • Bispecific antibodies
  • Products
    • Back
    • Overview
    • TE-1146
    • TE-1132
    • TE-8105
    • TE-8035
    • TE-8214
    • TE-6168
  • News&Honors
  • Contact Us
  • ( English )
    • Back
    • English
    • 繁體中文
  • Copyright © 2017 MIRACLE

News&Honors

Invited lectures on November 15th, 2022 Antibody Therapeutic Conference - Extended Application of Antibody
2022/11
15
Recognized as a biotechnology and pharmaceutical company by the Ministry of Economic Affairs, R. O. C.
2022/11
01
【Reported by Taiwan Global Bio Monthly】Precision therapy industry development & trends forum: Immunwork presents the latest progress
2022/07
14
【Taiwan Global Bio Monthly: Cover Story】Dr. Tse-Wen Chang founded Immunwork, completed foundraising of 670 million, potentially get licensed business opportunities
2022/06
16
【Reported by Taiwan Global Bio Monthly】Immunwork won the first prize of investment matchmaking competition
2022/04
29
  • 1
  • 2
  • 3
  • 4

Immunwork, Inc., a wholly owned subsidiary of T-E Pharma Holding, a Cayman Island company.

Address: Room C520, Building C, No. 99, Lane 130, Sec. 1, Academia Rd,, Nangang District, Taipei City, Taiwan R.O.C. 115202
Email: bd@immunwork.com or service@immunwork.com
Phone: +886-2-2651-2268
Design assisted by WebTech Webpage design
go top